Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solid Tumor × Cyclophosphamide × Clear all

Phase

Phase 1 4 Phase EARLY_PHASE1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 250 Lymphoma 240 Precursor Cell Lymphoblastic Leukemia-Lymphoma 191 Leukemia 177 Multiple Myeloma 166 Lymphoma, Large B-Cell, Diffuse 166 Lymphoma, Non-Hodgkin 152 Leukemia, Lymphocytic, Chronic, B-Cell 146 Leukemia, Myeloid, Acute 135 Myelodysplastic Syndromes 115 Hodgkin Disease 114 Lymphoma, Follicular 113 Burkitt Lymphoma 108 Lymphoma, Mantle-Cell 103 Lymphoma, B-Cell, Marginal Zone 76 Lymphoma, Large-Cell, Immunoblastic 64 Neoplasms, Plasma Cell 59 Recurrence 58 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 57 Myeloproliferative Disorders 53 Neoplasms 49 Leukemia, Myeloid, Chronic-Phase 49 Triple Negative Breast Neoplasms 47 Leukemia, Myeloid, Accelerated Phase 47 Melanoma 46 Leukemia, Myelomonocytic, Chronic 46 Dendritic Cell Sarcoma, Interdigitating 46 Waldenstrom Macroglobulinemia 42 Hematologic Neoplasms 41 Congenital Abnormalities 39

Interventions

apatinib 3 vistusertib 2 olaparib 2 camrelizumab 2 atezolizumab 2 Ipilimumab 2 Everolimus 2 trametinib 1 toripalimab 1 tilsotolimod 1 tazemetostat 1 tazarotene 1 spartalizumab 1 seviteronel 1 sargramostim 1 sacituzumab govitecan 1 rucaparib 1 roniciclib 1 romiplostim 1 pyrotinib 1 phosphorylethanolamine 1 pemigatinib 1 pembrolizumab 1 pazopanib 1 palbociclib 1 niraparib 1 magrolimab 1 lenvatinib 1 irinotecan sucrosofate 1 famitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04469530 2026-02-27

AflacST1903

Emory University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡